The artificial insemination industry in the DACH region focuses on reproductive health solutions, including fertility treatments and assisted reproduction technologies. Key players in the sector range from medical startups developing innovative treatments to established corporate firms enhancing these services. The growth of telemedicine and digital health is making fertility services more accessible, reshaping how couples seek help. Notably, recent advancements in technology are driving more data-driven approaches and personalized options in treatments, enhancing success rates and patient experiences. As societal attitudes shift towards family planning, the demand for these services is expected to rise, driving future investments and innovations.


The realm of artificial insemination investment in DACH features a mix of venture capital and corporate investors. Headquartered across Austria, Germany, and Switzerland, investors vary in size from startups to major corporations, established anywhere from 2000 to 2020. For 2024, several active participants made a significant number of deals, especially in the realm of reproductive health startups. This landscape highlights a growing understanding of investment opportunities in a sector poised for expansion, seen through the engagements of firms like Speedinvest and Ferring Pharmaceuticals.


Top 17 Artificial Insemination Investors in DACH


1. Calm/Storm

  • Website: calmstorm.vc
  • Type: Venture Capital
  • Headquarters: Vienna, Vienna, Austria
  • Founded year: 2020
  • Headcount: 1-10
  • Number of deals in 2024: 13
  • LinkedIn: calm-storm

Calm/Storm Ventures is a venture capital firm based in Vienna, Austria, founded in 2020. The firm specializes in early-stage investments in health tech startups, emphasizing purpose-driven founders. They provide capital, support, and networking opportunities to help these companies thrive in the competitive health tech landscape. Notably, Calm/Storm has invested in Béa Fertility, a startup that aims to make clinical-grade fertility treatments accessible at home, which is directly relevant to artificial insemination. They also participated in a funding round for Inne, a health tech startup that is expanding its platform and entering the contraceptive market, further showcasing their interest in reproductive health. Their portfolio reflects a commitment to addressing sensitive health issues, making them a significant player in the health tech and fertility sectors.


2. Fresenius Netcare GMBH

  • Website: fresenius.com
  • Type: Corporate
  • Headquarters: Geisenheim, Hesse, Germany
  • Headcount: 10001+
  • LinkedIn: iteanova

Fresenius Netcare GMBH is a corporate investor based in Geisenheim, Hesse, Germany, and is part of Fresenius SE & Co. KGaA, a leading healthcare provider specializing in lifesaving medicines and technologies. The company operates through subsidiaries such as Fresenius Kabi and Fresenius Helios, serving healthcare providers, hospitals, and clinics with a range of biopharmaceuticals and medical technologies. Notably, Fresenius Helios acquired Eugin Group on December 21, 2020, for approximately $526 million. Eugin Group is a prominent player in the field of assisted reproductive technologies, including artificial insemination, which aligns with the investor's involvement in the artificial insemination sector. Additionally, Fresenius has made other significant acquisitions in the healthcare space, such as Quirónsalud, Spain's largest private hospital operator, further demonstrating their commitment to expanding their healthcare services.


3. Ferring Pharmaceuticals


Ferring Pharmaceuticals is a biopharmaceutical company founded in 1950, headquartered in Saint-Prex, Vaud, Switzerland. The company specializes in reproductive health, maternal health, gastroenterology, and urology, developing and manufacturing innovative treatments aimed at improving the quality of life for patients. Notably, Ferring has been involved in significant transactions such as the acquisition of BioSET in 2015, which may enhance their capabilities in reproductive technologies. Additionally, they participated in a substantial funding round for FerGene in 2019, although this transaction is less directly related to artificial insemination. Overall, Ferring's focus on reproductive health positions them as a relevant player in the artificial insemination industry.


4. Speedinvest

  • Website: speedinvest.com
  • Type: Venture Capital
  • Headquarters: Vienna, Vienna, Austria
  • Founded year: 2011
  • Headcount: 51-200
  • Number of deals in 2024: 45
  • LinkedIn: speedinvest

Speedinvest is a venture capital firm based in Vienna, Austria, founded in 2011. The firm specializes in funding early-stage tech startups across Europe, providing both capital and hands-on support to help these companies scale. Their investment focus spans various technology sectors, including Deep Tech, Fintech, and SaaS. Recently, Speedinvest has made notable investments in the reproductive health space, including a seed funding round for Fertifa, a startup dedicated to reproductive health, and The Lowdown, a platform focused on sexual and reproductive health. These transactions highlight Speedinvest's commitment to supporting innovations in the reproductive health sector, making them a relevant player in the artificial insemination industry.


5. TA Ventures

  • Website: taventures.vc
  • Type: Venture Capital
  • Headquarters: Frankfurt, Hesse, Germany
  • Founded year: 2010
  • Headcount: 11-50
  • Number of deals in 2024: 5
  • LinkedIn: ta-ventures

TA Ventures is a venture capital firm based in Frankfurt, Hesse, Germany, founded in 2010. The firm specializes in early-stage technology startups across various sectors, including HealthTech and FinTech. With a focus on providing capital and strategic support, TA Ventures aims to help startups thrive in competitive markets. Notably, they have invested in Fertilly, which raised funds in a Seed Round in June 2021, indicating their interest in the fertility sector. Additionally, they have been involved with Gameto, a biotech company that has raised significant capital in multiple funding rounds (including $20 million in Series A and $33 million in Series B) and is working on preclinical development partnerships with fertility clinics worldwide. This involvement highlights TA Ventures' engagement in the fertility and artificial insemination space, showcasing their commitment to supporting innovations that can enhance reproductive health.


6. b2venture

  • Website: b2venture.vc
  • Type: Venture Capital
  • Headquarters: St. Gallen, St. Gallen, Switzerland
  • Founded year: 2000
  • Headcount: 11-50
  • Number of deals in 2024: 15
  • LinkedIn: btovpartners

b2venture is a venture capital firm based in St. Gallen, Switzerland, founded in 2000. The firm specializes in early-stage investments in innovative startups across various sectors, providing financial backing and support to entrepreneurs. They collaborate with a community of angel investors, enhancing their investment strategy and positioning them as a key player in the European venture capital landscape. Notably, b2venture has invested in Ava, a company that raised $30 million in Series B funding to enhance products aimed at helping women manage their reproductive health. This involvement highlights b2venture's interest in the reproductive health sector, which is closely related to artificial insemination. Additionally, their investments in UroMems, a company focused on urological solutions, further demonstrate their engagement in health-related technologies, although not directly in artificial insemination.


7. Atlantic Labs

  • Website: atlanticlabs.de
  • Type: Venture Capital
  • Headquarters: Berlin, Berlin, Germany
  • Founded year: 2013
  • Headcount: 11-50
  • Number of deals in 2024: 13
  • LinkedIn: atlantic-labs

Atlantic Labs is a venture capital firm based in Berlin, Germany, founded in 2013. The firm supports exceptional, mission-driven founders throughout their entrepreneurial journey, focusing on startups across various sectors, including climate tech, AI, and digital health. Notably, Atlantic Labs has invested in Clue, a fertility tracking app that has raised significant funding over the years, including a Series A round of $7 million in 2015 and a Series B round of $20 million in 2016. These investments highlight their interest in the fertility and reproductive health space. Additionally, they have invested in LEVY Health, a female-led startup that raised $4.5 million in a Seed Round in 2024, further demonstrating their commitment to health-related ventures. Through these transactions, Atlantic Labs provides both capital and strategic guidance to help these businesses grow, particularly in the context of fertility and women's health.


8. Ananda Impact Ventures

  • Website: ananda.vc
  • Type: Venture Capital
  • Headquarters: Munich, Bavaria, Germany
  • Founded year: 2010
  • Headcount: 11-50
  • Number of deals in 2024: 6
  • LinkedIn: anandaventures

Ananda Impact Ventures is an impact investment firm based in Munich, Bavaria, Germany, founded in 2010. The firm specializes in supporting early-stage companies that aim to create significant social and environmental impact. They provide both investment and strategic support to entrepreneurs across various sectors, including healthcare, education, and sustainability. In 2024, Ananda Impact Ventures participated in a seed round for Ovom Care, which raised approximately $5.1 million. Ovom Care is relevant to the artificial insemination context as it focuses on reproductive health solutions. Additionally, they co-invested in the acquisition of Doktor 24, a healthcare services provider in Hungary, although this transaction is less directly related to artificial insemination. Overall, their involvement in healthcare and specific transactions like Ovom Care indicate a potential interest in the artificial insemination sector, but their broader investment strategy encompasses a wider range of industries.


9. IBB Ventures


IBB Ventures is a venture capital firm based in Berlin, Germany, founded in 1997. The firm specializes in providing funding and support to innovative startups, particularly in the early stages of their development. With a portfolio of over 270 startups, IBB Ventures offers not only financial backing but also expertise and resources to help these businesses thrive in competitive markets. One notable transaction in their portfolio is the investment in Fertilly, which raised an undisclosed amount in a Seed Round on June 30, 2021. Fertilly is involved in the artificial insemination sector, showcasing IBB Ventures' engagement in this industry alongside their broader investment strategy.


10. Wille Finance

  • Website: willefinance.com
  • Type: Venture Capital
  • Headquarters: Zug, Zug, Switzerland
  • Founded year: 2007
  • Headcount: 11-50
  • Number of deals in 2024: 12
  • LinkedIn: willefinance

Wille Finance is a venture capital firm based in Zug, Switzerland, founded in 2007. The firm specializes in private equity and real estate investments, providing capital and operational support to both growth companies and established businesses. Wille Finance employs a mix of venture capital and buyout strategies to enhance the operations of its portfolio companies. In 2021, Wille Finance participated in a seed round investment for Fertilly, a company that operates in the artificial insemination sector. This transaction highlights Wille Finance's engagement with innovative companies in the reproductive health space, showcasing their versatility in investment across various sectors, including artificial insemination.


11. Partners Group

  • Website: partnersgroup.com
  • Type: Private Equity
  • Headquarters: Baar, Zug, Switzerland
  • Founded year: 1996
  • Headcount: 1001-5000
  • Number of deals in 2024: 19
  • LinkedIn: partners-group

Partners Group Holding AG is a prominent investment management firm based in Baar, Zug, Switzerland, specializing in private equity, private infrastructure, private real estate, and private debt. Founded in 1996, the firm manages over USD 149 billion in assets and is recognized for its innovative investment strategies and commitment to sustainability. Notably, Partners Group has made significant strides in the healthcare sector, exemplified by their acquisition of Axia Women's Health, a leading provider of women's healthcare services in the US, which includes reproductive health services. This acquisition, announced on May 5, 2021, positions Partners Group as a key player in the women's health market, potentially linking them to the artificial insemination industry. Additionally, their acquisition of Forefront Dermatology further demonstrates their active engagement in healthcare investments, reinforcing their strategy to diversify within the health sector.


12. Fly Ventures

  • Website: fly.vc
  • Type: Venture Capital
  • Headquarters: Berlin, Berlin, Germany
  • Founded year: 2016
  • Headcount: 1-10
  • Number of deals in 2024: 2
  • LinkedIn: fly-ventures

Fly Ventures is a venture capital firm based in Berlin, Germany, founded in 2016. The firm specializes in investing in early-stage technology companies across Europe, with a strong emphasis on supporting technical founders who tackle complex challenges. In recent years, Fly Ventures has been involved in notable transactions, including investments in ImVitro, a company focused on artificial insemination. ImVitro raised $2.5M in a funding round in December 2022 and previously secured funding in a pre-seed round in March 2020. These investments highlight Fly Ventures' engagement in the artificial insemination sector, showcasing their commitment to fostering innovation in this area.


13. La Famiglia

  • Website: lafamiglia.vc
  • Type: Venture Capital
  • Headquarters: Berlin, Berlin, Germany
  • Founded year: 2016
  • Headcount: 11-50
  • Number of deals in 2024: 4
  • LinkedIn: la-famiglia-vc

La Famiglia is a venture capital fund based in Berlin, Germany, founded in 2016. The firm specializes in early-stage and growth-stage investments in technology companies, supporting tech entrepreneurs with capital, market access, and strategic partnerships. La Famiglia aims to enable disruptive innovations across various industries by leveraging the expertise of world-leading entrepreneurs in its network. One of their notable transactions includes participating in a $90 million Series E funding round for Maven Clinic, a company that offers fertility and family-building services, including artificial insemination. This investment highlights La Famiglia's engagement in the reproductive health sector, showcasing their interest in companies that address critical family planning and fertility issues.


14. Alpana Ventures

  • Website: alpana-ventures.ch
  • Type: Venture Capital
  • Headquarters: Geneva, Geneva, Switzerland
  • Founded year: 2016
  • Headcount: 1-10
  • Number of deals in 2024: 1
  • LinkedIn: alpana-ventures

Alpana Ventures is a venture capital firm based in Geneva, Switzerland, founded in 2016. The firm specializes in digital transformation and invests in startups across various sectors, including technology and healthcare. Alpana Ventures provides funding and strategic consulting to help entrepreneurs navigate the challenges of launching and scaling their businesses. Notably, they have invested in Ava, a Swiss-based company that raised $30 million in Series B funding in 2018 and $9.7 million in Series A funding in 2016. Ava focuses on developing applications that assist women in understanding their bodies and managing reproductive health, making Alpana Ventures a relevant player in the artificial insemination and fertility space.


15. Swisscom Ventures


Swisscom Ventures is a venture capital firm based in Zurich, Switzerland, founded in 2007. The firm specializes in investing in high-potential technology startups, providing not only financial support but also strategic advisory services to help these startups access technical infrastructure and market channels. Swisscom Ventures operates across various technology sectors, including AI and Fintech. Notably, they have invested in Ava, a company that raised $9.7 million in a Series A round in November 2016 and $2.6 million in a Seed round in November 2015. Ava's focus on women's health and fertility tracking positions it within the artificial insemination context, making Swisscom Ventures a relevant investor in this field.


16. Helvetica Capital AG


Helvetica Capital AG is a private equity investment firm based in Zurich, Switzerland, founded in 2015. The firm specializes in providing capital and advisory services to Swiss small and medium-sized enterprises (SMEs), focusing on management buy-outs and growth capital investments. Helvetica Capital AG aims to help businesses navigate financial challenges and achieve sustainable development. One of their notable transactions includes a Series B funding round for Ava, a Swiss-based company that raised $30 million to enhance its product offerings and develop new applications aimed at helping women understand their bodies and manage their reproductive health. This investment indicates Helvetica Capital AG's engagement in the reproductive health sector, which is relevant to the artificial insemination industry.


17. Berlin Angel Fund


Berlin Angel Fund (BACB Beteiligungsgesellschaft mbH) is a venture capital firm based in Berlin, Germany, founded in 2019. The fund specializes in investing in startups and providing active support from initial funding to scaling. It connects entrepreneurs with experienced business angels, offering both financial investment and mentorship to help them succeed. In 2024, the fund was involved in a venture round for Femna Health, which raised an undisclosed amount. While the specific focus of Femna Health is not detailed, its involvement suggests that the Berlin Angel Fund is interested in health-related startups, potentially including those in the artificial insemination sector.



Artificial Insemination Insights: Key Investors in DACH


InvestorHeadquarterSizeFoundedDeals 2024
Calm/StormVienna, Vienna, Austria1-10202013
Fresenius Netcare GMBHGeisenheim, Hesse, Germany10001+0
Ferring PharmaceuticalsSaint-Prex, Vaud, Switzerland5001-1000019500
SpeedinvestVienna, Vienna, Austria51-200201145
TA VenturesFrankfurt, Hesse, Germany11-5020105
b2ventureSt. Gallen, St. Gallen, Switzerland11-50200015
Atlantic LabsBerlin, Berlin, Germany11-50201313
Ananda Impact VenturesMunich, Bavaria, Germany11-5020106
IBB VenturesBerlin, Berlin, Germany11-50199718
Wille FinanceZug, Zug, Switzerland11-50200712
Partners GroupBaar, Zug, Switzerland1001-5000199619
Fly VenturesBerlin, Berlin, Germany1-1020162
La FamigliaBerlin, Berlin, Germany11-5020164
Alpana VenturesGeneva, Geneva, Switzerland1-1020161
Swisscom VenturesZurich, Zurich, Switzerland11-5020074
Helvetica Capital AGZurich, Zurich, Switzerland11-5020151
Berlin Angel FundBerlin, Berlin, Germany1-1020192


Want to find more investors focusing on the artificial insemination industry?

If you want to find more investors that are active in the artificial inseminationindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and there are a lot more private equity, venturecapital, and corporate investors like these globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and their sizes.
  • Portfolio: Companies they've invested in.
  • Contact data: Key dealmakers, including their emails and phonenumbers.
  • ...and much more!